NCT06777537View on ClinicalTrials.gov

Neoadjuvant Chemotherapy with or Without Talniflumate for the Treatment of Breast Cancer

PHASE4Not yet recruitingINTERVENTIONAL

Enrollment

200

Participants

Timeline

Start Date

June 1, 2025

Primary Completion Date

December 1, 2030

Study Completion Date

December 1, 2030

Conditions

Breast Cancer

Interventions

DRUG

Talniflumate

Talniflumate was administered

All Listed Sponsors

lead

Shandong University

OTHER